|
In just concluded Meeting of Board of Directors, the Board Approved and considered the following items:
1. Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30, 2025 (annexed herewith);
2. Limited review reports from the Statutory Auditor on Unaudited (Standalone and Consolidated) Financial Statements for the Quarter and Half year ended September 30, 2025 (annexed here with);
3. Other Business items.
We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 5:00 PM.
This intimation is also uploaded on the Company website: www.gennexlab.com.
We request you to take the above information on record and acknowledge the receipt of the same.
|